We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 4 for:    fertile chip
Previous Study | Return to List | Next Study

The Effects of Using Fertile Chip in Sperm Selection for Intracytoplasmic Sperm Injection in Unexplained Infertility

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02488434
Recruitment Status : Completed
First Posted : July 2, 2015
Last Update Posted : August 12, 2016
Sponsor:
Information provided by (Responsible Party):
Selçuk Yetkinel, Baskent University

Brief Summary:
The aim of the current study is to evaluate to effectiveness of sperm selection by using fertile chip in unexplained infertile couples on intracytoplasmic sperm injection (ICSI) cycles.

Condition or disease Intervention/treatment Phase
Unexplained Infertility Device: fertile chip Phase 3

Detailed Description:

The aim of the current study is to evaluate to effectiveness of sperm selection by using fertile chip in unexplained infertile couples on intracytoplasmic sperm injection (ICSI) cycles. On study arm sperm selection will be performed by using special microchannel system which is called fertile chip (FC) without using sperm wash procedure. This FC system leads to select lineer motile progressive sperm selection. In control group, sperm selection will be performed by classical way which sperm will be undertaken to sperm wash by gradient method.

After selection of sperm in both arms, ICSI will be performed. The outcomes of ICSI schedule will be assesed by fertilization and clinical pregnancy rates.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 122 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: The Effectiveness of Using Fertile Chip on Intracytoplasmic Sperm Injection Undergoing Ivf Programme in Unexplained Infertile Couples
Study Start Date : June 2015
Actual Primary Completion Date : August 2016
Actual Study Completion Date : August 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Infertility

Arm Intervention/treatment
Active Comparator: fertile chip
sperm selection by using fertile chip and conventional methods
Device: fertile chip
a new method for sperm selection on ivf cycles by using microchannel system.

No Intervention: classical ICSI procedure
unexplained infertile couples who will be undertaken intracytoplasmic sperm injection (ICSI) for fertilisation



Primary Outcome Measures :
  1. increase fertilisation rate [ Time Frame: 2 days ]

Secondary Outcome Measures :
  1. Clinical pregnancy rates [ Time Frame: 10 months ]

Other Outcome Measures:
  1. The number of freezing embryos [ Time Frame: 6 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 40 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • between 20-37 year-old women
  • normal tubal patency, normal uterine cavity, normal ovulation,
  • between 20-40 year-old men
  • normal semen analyse by WHO criterias
  • unexplained infertile couples

Exclusion Criteria:

  • poor ovarian reserve which is diagnosed by Bologna criterias
  • abnormal semen analyse by WHO sperm criterias
  • abnormal ovulation problems,tubal patency or uterine cavity

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02488434


Locations
Layout table for location information
Turkey
Baskent University Faculty of Medicine Department of Obstetrics and Gynecology Division of Reproductive and Endocrinology Unit
Adana, Yüreğir, Turkey
Sponsors and Collaborators
Baskent University
Investigators
Layout table for investigator information
Study Director: Esra Bulgan Kılıçdağ, MD Division of Reproductive and Endocrinology Unit, Department of Obstetrics and Gynecology, Faculty of Medicine, Baskent University, Adana, Turkey
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Selçuk Yetkinel, Clinical Doctor, Baskent University
ClinicalTrials.gov Identifier: NCT02488434    
Other Study ID Numbers: KA15/132
First Posted: July 2, 2015    Key Record Dates
Last Update Posted: August 12, 2016
Last Verified: August 2016
Keywords provided by Selçuk Yetkinel, Baskent University:
ICSI
sperm selection
fertile chip
ıcsı outcomes
Additional relevant MeSH terms:
Layout table for MeSH terms
Infertility